Robin Harper Cowie has been with Biodesix since March 2011 and has served as Chief Financial Officer since April 2017. She brings deep expertise in finance, government policy, reimbursement, and operations. She has a passionate personal mission to bring access to Biodesix diagnostic testing for every person who needs them.
Prior to joining Biodesix, Robin held a leadership role in payor and government relations at Precision Therapeutics, Inc. Robin’s background includes corporate finance, managed care and payor relations, government reimbursement and regulatory policy, legal affairs, health economics and outcomes research, analytics, customer service and billing operations. She also served as a laboratory researcher for several years at the University of Pittsburgh Medical Center researching migraine, epilepsy, and ALS. Robin holds a B.S. in Molecular Biology from the University of Pittsburgh, and an M.B.A. in Finance from the Joseph M. Katz Graduate School of Business from the University of Pittsburgh.
Robin Harper Cowie
Posted
in
by
Tags: